Mono versus Dual Antiplatelet Therapy after Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis

References

• Leon MB , Smith CR , Mack M , et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. New England J Med . 2010;363(17):1597–1607. doi:10.1056/NEJMoa1008232.
   PubMed Web of Science ®Google Scholar
• Hafiz AM , Kalra A , Ramadan R , et al. Clinical or symptomatic leaflet thrombosis following transcatheter aortic valve replacement: insights from the US FDA MAUDE database. Struct Heart . 2017;1 (5–6):256–264.
   Google Scholar
• Mack MJ , Brennan JM , Brindis R , et al. Outcomes following transcatheter aortic valve replacement in the United States. Jama . 2013;310(19):2069–2077. doi:10.1001/jama.2013.282043.
   PubMed Web of Science ®Google Scholar
• Nishimura RA , Otto CM , Bonow RO , et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation . 2017;135(25):e1159–e1195. doi:10.1161/CIRCULATIONAHA.117.027305.
   PubMed Web of Science ®Google Scholar
• Hassell ME , Hildick-Smith D , Durand E , et al. Antiplatelet therapy following transcatheter aortic valve implantation. Heart . 2015;101:1118–1125. heartjnl-2014-307053. doi:10.1136/heartjnl-2014-307053.
   PubMed Web of Science ®Google Scholar
• Gandhi S , Schwalm J-DR , Velianou JL , Natarajan MK , Farkouh ME. Comparison of dual-antiplatelet therapy to mono-antiplatelet therapy after transcatheter aortic valve implantation: systematic review and meta-analysis. Can J Cardiol . 2015;31(6):775–784. doi:10.1016/j.cjca.2015.01.014.
   Web of Science ®Google Scholar
• Aryal MR , Karmacharya P , Pandit A , et al. Dual versus single antiplatelet therapy in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis. Heart, Lung Circ . 2015;24(2):185–192. doi:10.1016/j.hlc.2014.07.058.
   PubMed Web of Science ®Google Scholar
• Verdoia M , Barbieri L , Nardin M , Suryapranata H , de Luca G. Dual versus single antiplatelet regimen with or without anticoagulation in transcatheter aortic valve replacement: indirect comparison and meta-analysis. Revista Española de Cardiología (English Edition) . 2017;7(4):257–266.
   Web of Science ®Google Scholar
• Moher D , Liberati A , Tetzlaff J , Altman DG , Group P . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg . 2010;8(5):336–341. doi:10.1016/j.ijsu.2010.02.007.
   PubMed Web of Science ®Google Scholar
• Rodés-Cabau J , Masson J-B , Welsh RC , et al. Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve: the ARTE (Aspirin Versus Aspirin+ Clopidogrel following transcatheter aortic valve implantation) randomized clinical trial. JACC . 2017.
   Google Scholar
• Stabile E , Pucciarelli A , Cota L , et al. SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation. Int J Cardiol . 2014;174(3):624–627. doi:10.1016/j.ijcard.2014.04.170.
   PubMed Web of Science ®Google Scholar
• Ussia GP , Scarabelli M , Mulè M , et al. Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am J Cardiol . 2011;108(12):1772–1776. doi:10.1016/j.amjcard.2011.07.049.
   PubMed Web of Science ®Google Scholar
• Hioki H , Watanabe Y , Kozuma K , et al. Pre-procedural dual antiplatelet therapy in patients undergoing transcatheter aortic valve implantation increases risk of bleeding. Heart . 2017;103(5):361–367. doi:10.1136/heartjnl-2016-309735.
   Web of Science ®Google Scholar
• Ichibori Y , Mizote I , Maeda K , et al. Clinical outcomes and bioprosthetic valve function after transcatheter aortic valve implantation under dual antiplatelet therapy vs. aspirin alone. Circ J . 2017;81(3):397–404. doi:10.1253/circj.CJ-16-0903.
   Web of Science ®Google Scholar
• Mangieri A , Jabbour RJ , Montalto C , et al. Single-antiplatelet therapy in patients with contraindication to dual-antiplatelet therapy after transcatheter aortic valve implantation. Am J Cardiol . 2017;119(7):1088–1093. doi:10.1016/j.amjcard.2016.11.065.
   Web of Science ®Google Scholar
• Durand E , Blanchard D , Chassaing S , et al. Comparison of two antiplatelet therapy strategies in patients undergoing transcatheter aortic valve implantation. Am J Cardiol . 2014;113(2):355–360. doi:10.1016/j.amjcard.2013.09.033.
   PubMed Web of Science ®Google Scholar
• Poliacikova P , Cockburn J , de Belder A , Trivedi U , Hildick-Smith D . Antiplatelet and antithrombotic treatment after transcatheter aortic valve implantation-comparison of regimes. J Invasive Cardiol . 2013;25:544–548.
   PubMed Web of Science ®Google Scholar
• D’Ascenzo F , Benedetto U , Bianco M , et al. Which is the best anti-aggregant or anti-coagulant therapy after TAVI? EuroIntervention . 2014;13(12):e1392–e1400.
   Google Scholar
• Sherwood MW , Vemulapalli S , Vora AN , et al. National variation in post-TAVR antithrombotic therapy utilization in patients with atrial fibrillation: insights from the STS/ACC TVT Registry®. Am Heart Assoc . 2015.
   Google Scholar
• Chandrasekhar J , Chieffo A , Petronio A , et al. Impact of single versus dual anti platelet therapy on early outcomes in women undergoing transcatheter aortic valve replacement: from the WIN-TAVI registry. J Am Coll Cardiol . 2017;69(11 Supplement):1205. doi:10.1016/j.jacc.2016.11.026.
   Web of Science ®Google Scholar
• De La Torre Hernandez JVFG , Telleria M , Lee D , et al. Dual vs. single antiplatelet therapy after transaortic valve implantation: a prospective multicentre study. EuroIntervention . 2016. ABSTRACTS EUROPCR 2016. https://www.pcronline.com/eurointervention/AbstractsEuroPCR2016_issue/abstracts-europcr-2016/Euro16A-POS0364/dual-vs-single-antiplatelet-therapy-after-transaortic-valve-implantation-a-prospective-multicentre-study.html
   Google Scholar
• Tay EL , Gurvitch R , Wijesinghe N , et al. A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2011;4(12):1290–1297.
   Google Scholar
• Uddin A , Gurvitch R , Wijesinghe N , et al. A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. JACC . 2011;4(12):1290–1297. doi:10.1016/j.jcin.2011.08.012.
   Web of Science ®Google Scholar
• Uddin A , Fairbairn TA , Djoukhader IK , et al. Consequence of cerebral embolism after transcatheter aortic valve implantation compared with contemporary surgical aortic valve replacement. Circulation . 2015;8(3):e001913.
   Web of Science ®Google Scholar
• Kapadia SR , Leon MB , Makkar RR , et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. The Lancet . 2015;385(9986):2485–2491. doi:10.1016/S0140-6736(15)60290-2.
   PubMed Web of Science ®Google Scholar
• Auffret V , Regueiro A , Del Trigo M , et al. Predictors of early cerebrovascular events in patients with aortic stenosis undergoing transcatheter aortic valve replacement. J Am Coll Cardiol . 2016;68(7):673–684. doi:10.1016/j.jacc.2016.05.065.
   PubMed Web of Science ®Google Scholar
• Toyoda K , Ninomiya T . Stroke and cerebrovascular diseases in patients with chronic kidney disease. Lancet Neurol . 2014;13(8):823–833. doi:10.1016/S1474-4422(14)70026-2.
   PubMed Web of Science ®Google Scholar
• Nombela-Franco L , Webb JG , de Jaegere P , et al. Timing, predictive factors and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation . 2012. CIRCULATIONAHA. 112.110981. doi:10.1161/CIRCULATIONAHA.112.110981.
   Web of Science ®Google Scholar
• Site HG . Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet . 2006;367(9526):1903–1912. doi:10.1016/S0140-6736(06)68845-4.
   PubMed Web of Science ®Google Scholar
• Wong DR , Ye J , Cheung A , Webb JG , Carere RG , Lichtenstein SV . Technical considerations to avoid pitfalls during transapical aortic valve implantation. J Thorac Cardiovasc Surg . 2010;140(1):196–202. doi:10.1016/j.jtcvs.2009.07.081.
   Web of Science ®Google Scholar
• Halliday BP , Dworakowski R , Brickham B , Wendler O , MacCarthy P . Usefulness of periprocedural bleeding to predict outcome after transcatheter aortic valve implantation. Am J Cardiol . 2012;109(5):724–728. doi:10.1016/j.amjcard.2011.10.034.
   Web of Science ®Google Scholar
• Van Mieghem NM , Nuis R-J , Tzikas A , et al. Prevalence and prognostic implications of baseline anaemia in patients undergoing transcatheter aortic valve implantation. EuroIntervention . 2011;7(2):184–191. doi:10.4244/EIJV7I2A32.
   Web of Science ®Google Scholar
• Généreux P , Cohen DJ , Williams MR , et al. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol . 2014;63(11):1100–1109. doi:10.1016/j.jacc.2013.10.058.
   PubMed Web of Science ®Google Scholar
• McQuaid KR , Laine L . Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med . 2006;119(8):624–638. doi:10.1016/j.amjmed.2005.10.039.
   PubMed Web of Science ®Google Scholar
• Ghanem A , Dörner J , Schulze-Hagen L , et al. Subacute subclinical brain infarctions after transcatheter aortic valve implantation negatively impact cognitive function in long-term follow-up. PloS One . 2017;12(1):e0168852. doi:10.1371/journal.pone.0168852.
   Web of Science ®Google Scholar